Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Capstone MiningMorgan Advanced MaterialsFIH MobileAcacia MiningZealand Pharma A/S
SymbolOTCMKTS:CSFFFOTCMKTS:MCRUFOTCMKTS:FXCNYOTCMKTS:ABGLFOTCMKTS:ZLDPF
Price Information
Current Price$3.50$4.31$3.05$3.09$32.60
52 Week RangeBuyHoldN/AN/AN/A
MarketRank™
Overall Score0.91.00.50.30.5
Analysis Score1.50.00.00.00.0
Community Score2.82.02.11.72.3
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.03.10.60.00.0
Analyst Ratings
Consensus RecommendationBuyHoldN/AN/AN/A
Consensus Price Target$1.37N/AN/AN/AN/A
% Upside from Price Target-60.95% downsideN/AN/AN/AN/A
Trade Information
Market Cap$1.43 billion$1.23 billion$1.23 billion$1.27 billion$1.17 billion
Beta2.320.711.380.110.65
Average Volume89,5764,41410,84132,275209
Sales & Book Value
Annual Revenue$418.66 million$1.34 billion$14.38 billion$663.79 million$6.20 million
Price / Sales3.420.920.091.91188.24
Cashflow$0.31 per share$0.59 per share$0.39 per shareN/AN/A
Price / Cash11.447.357.90N/AN/A
Book Value$2.18 per share$1.40 per share$5.11 per shareN/A$5.20 per share
Price / Book1.613.080.606.27
Profitability
Net Income$-16,040,000.00$93.34 million$-12,290,000.00$58.87 million$-85,670,000.00
EPSN/A$0.35N/AN/AN/A
Trailing P/E RatioN/A12.310.000.00N/A
Forward P/E Ratio15.96
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-0.40%N/AN/AN/A-296.37%
Return on Equity (ROE)-1.91%N/AN/AN/A-57.25%
Return on Assets (ROA)-1.22%N/AN/AN/A-45.40%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.25%0.67%N/AN/AN/A
Current Ratio2.09%1.51%1.21%N/A6.76%
Quick Ratio1.35%1.01%1.01%N/A6.51%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees1,0498,56071,6541,331329
Shares Outstanding409.64 million285.37 million404.24 million410.09 million35.80 million
Next Earnings Date4/27/2021 (Estimated)N/A4/15/2021 (Estimated)N/A5/13/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Head to Head Contrast: The Sage Group (OTCMKTS:SGPYY) vs. Zealand Pharma A/S (OTCMKTS:ZLDPF)Head to Head Contrast: The Sage Group (OTCMKTS:SGPYY) vs. Zealand Pharma A/S (OTCMKTS:ZLDPF)
americanbankingnews.com - April 10 at 10:16 AM
Zealand Pharma A/S (OTCMKTS:ZLDPF) Reaches New 1-Year Low at $31.40Zealand Pharma A/S (OTCMKTS:ZLDPF) Reaches New 1-Year Low at $31.40
americanbankingnews.com - April 5 at 8:06 PM
Total number of shares and voting rights in Zealand Pharma at March 31, 2021Total number of shares and voting rights in Zealand Pharma at March 31, 2021
finance.yahoo.com - March 31 at 7:53 AM
Zealand Pharma A/S (OTCMKTS:ZLDPF) Reaches New 12-Month Low at $31.40Zealand Pharma A/S (OTCMKTS:ZLDPF) Reaches New 12-Month Low at $31.40
americanbankingnews.com - March 30 at 7:06 PM
Zealand Pharma A/S (ZLDPF)Zealand Pharma A/S (ZLDPF)
uk.finance.yahoo.com - March 27 at 3:15 PM
The Petri Dish: Pfizer signs licensing deal with oncology startup, Ikena sets IPO termsThe Petri Dish: Pfizer signs licensing deal with oncology startup, Ikena sets IPO terms
bizjournals.com - March 25 at 1:00 PM
Zealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 1-Year Low at $31.40Zealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 1-Year Low at $31.40
americanbankingnews.com - March 24 at 6:52 PM
Critical Comparison: Zealand Pharma A/S (OTCMKTS:ZLDPF) versus SMC (OTCMKTS:SMCAY)Critical Comparison: Zealand Pharma A/S (OTCMKTS:ZLDPF) versus SMC (OTCMKTS:SMCAY)
americanbankingnews.com - March 24 at 4:54 AM
Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment ...Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment ...
apnews.com - March 22 at 6:04 PM
Zealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment of Severe Hypoglycemia in People with DiabetesZealand Pharma Announces FDA Approval of Zegalogue® (dasiglucagon) injection, for the Treatment of Severe Hypoglycemia in People with Diabetes
finance.yahoo.com - March 22 at 6:04 PM
Zealand Pharma A-S is about to announce its earnings — heres what Wall Street expectsZealand Pharma A-S is about to announce its earnings — here's what Wall Street expects
markets.businessinsider.com - March 9 at 1:14 PM
Zealand Pharma Virtual R&D Day Materials Now Available with Live Q&A Session on March 5, 2021Zealand Pharma Virtual R&D Day Materials Now Available with Live Q&A Session on March 5, 2021
finance.yahoo.com - March 4 at 10:16 AM
Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare ConferenceZealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference
finance.yahoo.com - February 9 at 4:42 PM
News for Zealand Pharma A-SNews for Zealand Pharma A-S
markets.businessinsider.com - December 24 at 8:19 AM
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants | BenzingaZealand Pharma increases its share capital as a consequence of exercise of employee warrants | Benzinga
benzinga.com - December 12 at 12:34 PM
Total number of shares and voting rights in Zealand Pharma at November 30, 2020Total number of shares and voting rights in Zealand Pharma at November 30, 2020
finance.yahoo.com - November 30 at 3:14 AM
Where Do Hedge Funds Stand On Zealand Pharma A/S (ZEAL)?Where Do Hedge Funds Stand On Zealand Pharma A/S (ZEAL)?
finance.yahoo.com - November 26 at 10:24 PM
Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q3 2020 Results - Earnings Call TranscriptZealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 6:00 PM
Zealand Pharma continues to advance clinical programs and commercial launch capabilities and presents financial results for the first nine months of 2020Zealand Pharma continues to advance clinical programs and commercial launch capabilities and presents financial results for the first nine months of 2020
finance.yahoo.com - November 12 at 12:59 PM
Zealand Pharma A/S. (ZLDPF)Zealand Pharma A/S. (ZLDPF)
nasdaq.com - November 4 at 11:57 PM
Total number of shares and voting rights in Zealand Pharma at September 30, 2020Total number of shares and voting rights in Zealand Pharma at September 30, 2020
finance.yahoo.com - October 7 at 1:45 PM
Zealand Pharma grants warrants and restricted share units under the employee warrant program and management long-term incentive programZealand Pharma grants warrants and restricted share units under the employee warrant program and management long-term incentive program
finance.yahoo.com - September 14 at 12:32 PM
Total number of shares and voting rights in Zealand Pharma at August 31, 2020Total number of shares and voting rights in Zealand Pharma at August 31, 2020
finance.yahoo.com - August 31 at 1:55 PM
Zealand Pharma A/S (ZEAL) Q2 2020 Earnings Call TranscriptZealand Pharma A/S (ZEAL) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 14 at 8:54 AM
Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal® rescue pen; pipeline progress includingZealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal® rescue pen; pipeline progress including
finance.yahoo.com - August 13 at 9:10 AM
DateCompanyBrokerageAction
4/12/2021Capstone MiningScotiabankReiterated Rating
3/22/2021Capstone MiningRoyal Bank of CanadaUpgrade
2/25/2021Capstone MiningCanaccord GenuityReiterated Rating
2/25/2021Capstone MiningBMO Capital MarketsReiterated Rating
12/17/2020Capstone MiningCIBCReiterated Rating
12/14/2020Capstone MiningScotia Howard WeillReiterated Rating
7/21/2020Capstone MiningNational Bank FinancialUpgrade
10/31/2018Capstone MiningHaywood SecuritiesUpgrade
1/20/2021Morgan Advanced MaterialsBerenberg BankDowngrade
4/3/2020Morgan Advanced MaterialsCitigroupReiterated Rating
(Data available from 4/12/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.